Artelo Biosciences (ARTL) Current Leases (2021 - 2025)

Artelo Biosciences (ARTL) has reported Current Leases for 5 consecutive years, with $40000.0 the latest figure, recorded in Q4 2025.

• On a quarterly basis, Current Leases rose 14.29% year-over-year to $40000.0 in Q4 2025; TTM through Dec 2025 was $40000.0, a 14.29% increase from a year earlier, with the FY2025 full-year figure at $40000.0, up 14.29% from the prior year.
• Current Leases was $40000.0 for Q4 2025 at Artelo Biosciences, up from $39000.0 in the prior quarter.
• Over five years, Current Leases peaked at $45000.0 in Q2 2022 and troughed at $23000.0 in Q4 2023.
• A 5-year average of $34888.9 and a median of $34500.0 in 2023 frame the typical range for Current Leases.
• Across the five-year window, Current Leases plunged 42.5% in 2023 and surged 52.17% in 2024, its largest moves.
• Over 5 years, Current Leases stood at $31000.0 in 2021, then gained by 29.03% to $40000.0 in 2022, then sank by 42.5% to $23000.0 in 2023, then soared by 52.17% to $35000.0 in 2024, then climbed by 14.29% to $40000.0 in 2025.
• The last three Current Leases figures came in at $40000.0 (Q4 2025), $39000.0 (Q3 2025), and $36000.0 (Q2 2025), per Business Quant data.